Medicxi Ventures Management (Jersey) Ltd Long-Term Concentrated

Name: Medicxi Ventures Management (Jersey) Ltd Q1 2020 13F Filing | 13F Explorer
Creator: Medicxi Ventures Management (Jersey) Ltd
Published: 2020-05-12

Location: St. Helier, Jersey

CIK: 0001715579 · Show all filings

Period: Q1 2020 (← Previous) (Next →)

Filing Date: May 12, 2020

Total Value: $76.53M (100.0% shares, 0.0% debt)

Holdings (3)

PHAT PHATHOM PHARMACEUTICALS INC 69.8%

Value $53.39M Shares 2,067,861 Est. Cost $25.13 Unrealized +33.0%

— MERUS N V 25.3%

Value $19.36M Shares 1,600,000 Est. Cost $14.08 Unrealized —

— OBSEVA SA 4.9%

Value $3.783M Shares 1,570,000 Est. Cost $3.82 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
PHAT	PHATHOM PHARMACEUTICALS INC	2,067,861	$53.39M	69.8%	$25.13	+33.0%	COM	71722W107
—	MERUS N V	1,600,000	$19.36M	25.3%	$14.08	—	COM	N5749R100
—	OBSEVA SA	1,570,000	$3.783M	4.9%	$3.82	—	COM	H5861P103